Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Genentech's Tecentriq Plus Avastin Combo Cuts Risk of Cancer Returning In Early-Stage Liver Cancer
January 19, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHBF
RHHVF
RHHBY
From
Benzinga
Trading Volume In The OTCQB Venture Market Picks Up in December – A Summary Of OTC Market Group's Most Active List In December
January 17, 2023
Tickers
AERG
ATLX
CLNV
CYDY
Tags
Partner Content
ZURVY
PVCT
From
Benzinga
Europe Approves Xofluza, Roche's Revolutionary Influenza Antiviral with New Mechanism
January 12, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Briefs
News
RHHBY
From
Benzinga
Twitter Hackers Stole More Than 200M Emails, Delta Air Lines To Offer Free Wi-Fi, Bed Bath & Beyond's Bankruptcy Coming Sooner Than Expected: Top Stories Today
January 06, 2023
Tickers
BBBY
CRM
DAL
PFE
Tags
Health Care
Biotech
Cryptocurrency
From
Benzinga
Roche's Investigational Lymphoma Candidate Goes Under FDA Priority Review
January 06, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHBY
General
News
From
Benzinga
Better Large-Cap Buy: Roche Holding or Gilead Sciences Stock?
January 02, 2023
Tickers
GILD
RHHBY
Tags
Recent Press Releases
RHHBY
Market News
From
Motley Fool
Roche's Follicular Lymphoma Therapy Scores FDA Approval
December 23, 2022
Tickers
BIIB
RHHBF
RHHBY
RHHVF
Tags
Large Cap
Biotech
Eurasia
From
Benzinga
FDA Approves Roche's Tocilizumab As First Monoclonal Antibody For COVID-19 Treatment
December 22, 2022
Tickers
LLY
RHHBF
RHHBY
RHHVF
Tags
RHHBF
RHHVF
General
From
Benzinga
Gilead Sciences (GILD) Stock Falls on Lung Cancer Drug Data
December 20, 2022
Tickers
GILD
MRK
RCUS
RHHBY
Tags
MRK
Market News
GILD
From
InvestorPlace
OTC Market Group's Most Active List In November: A Dive Into The Names Experiencing Volume Changes
December 13, 2022
Tickers
AAUKF
ASMIY
ATLX
BDRBF
Tags
VIHDD
JBSAY
Small Cap
From
Benzinga
Roche Presents New Data Demonstrating Potential Benefit Of Two Lymphoma Candidates
December 12, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Market News
RHHVF
RHHBF
From
Benzinga
Broadcom-Vmware Deal Draws European Regulatory Attention, Rivian Pauses Mercedes-Partnered EV Van Plans For Europe, Credit Suisse Issued Loan On Suspicious Bills: Top Stories Monday, Dec. 12
December 12, 2022
Tickers
AAL
AMGN
AMKBY
AMZN
Tags
Tech
BA
CS
From
Benzinga
After 16 Years, Roche's Pharma Division Head Decides To Step Down
December 12, 2022
Tickers
NSRGY
RHHBF
RHHBY
RHHVF
Tags
Large Cap
Biotech
Health Care
From
Benzinga
Exelixis' Cabometyx/Tecentriq Combo Misses Overall Survival Goal In Lung Cancer Setting
December 09, 2022
Tickers
EXEL
IPSEY
RHHBY
TAK
Tags
Benzinga
TAK
EXEL
From
Benzinga
3 Hot Stocks That Could Live Up to Their Lofty Valuations
December 08, 2022
Tickers
ABBV
GMAB
GTBIF
JNJ
Tags
RHHBY
ABBV
Recent Press Releases
From
Motley Fool
Replimune Shares Surge After Early Data From Pretreated Melanoma Patients
December 07, 2022
Tickers
BMY
REPL
RHHBF
RHHBY
Tags
RHHBY
General
Movers
From
Benzinga
Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors
December 02, 2022
Tickers
AMGN
CHRS
CYTK
IBB
Tags
AIDS
IMGN
Top Stories
From
Benzinga
This Congressman Just Purchased 2 Stocks Which Consistently Increase Dividends
November 28, 2022
Tickers
AEP
ARKG
INTC
RHHBY
Tags
AEP
General
ARKG
From
Benzinga
Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says
November 16, 2022
Tickers
AZN
AZNCF
GILD
GSK
Tags
AZN
Biotech
Health Care
From
Benzinga
FDA Gives Emergency Use Nod To Roche's Monkeypox Test
November 16, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Health Care
Biotech
Large Cap
From
Benzinga
Successful Alzheimer's Data Would Have Placed Roche At Two-Year Competitive Advantage
November 15, 2022
Tickers
BIIB
ESALY
LLY
RHHBF
Tags
Biotech
Large Cap
Health Care
From
Benzinga
Roche Inks Second Drug Discovery Deal With Jnana Therapeutics
November 15, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Market News
Benzinga
Biotech
From
Benzinga
FDA Grants Conditional Approval To First Antibody Drug Conjugate From ImmunoGen For Pretreated Ovarian Cancer
November 15, 2022
Tickers
IMGN
RHHBY
Tags
Movers
Briefs
News
From
Benzinga
Why Is Cassava Sciences (SAVA) Stock Up Today?
November 14, 2022
Tickers
BIIB
RHHBY
SAVA
Tags
Market News
SAVA
NASDAQ:SAVA,OTCMKTS:RHHBY,NASDAQ:BIIB
From
InvestorPlace
Roche's Alzheimer's Flop Trial Removes One Competitor, But Reimbursement Debate Lingers
November 14, 2022
Tickers
BIIB
ESALF
ESALY
MOR
Tags
why it's moving
Briefs
MOR
From
Benzinga
Why Is Biogen (BIIB) Stock Up Today?
November 14, 2022
Tickers
AMC
AMD
BIIB
RHHBY
Tags
AMC
Market News
Today's Market
From
InvestorPlace
The OTCQB Venture Market Records 4 Months Of Consecutive Volume Increases In OTC Market Group's Most-Active List In October
November 14, 2022
Tickers
AKZOY
CRTD
CURLF
DANOY
Tags
CRTD
ETHE
RHHBY
From
Benzinga
Roche's Another Alzheimer's Hopeful Flops In Phase 3 Program, Second Trial Setback Within Months
November 14, 2022
Tickers
MOR
RHHBF
RHHBY
RHHVF
Tags
RHHBF
RHHVF
why it's moving
From
Benzinga
Nasdaq, S&P 500 Futures Pullback At Start Of New Trading Week As Rate Fears Return To Haunt; AMD, Tesla, Biogen, Eli Lilly, JD In Focus
November 14, 2022
Tickers
AMD
BIIB
GOEV
JD
Tags
Economics
Previews
Federal Reserve
From
Benzinga
Why Shares Of Eli Lilly And Biogen Are Rallying Today
November 14, 2022
Tickers
BIIB
ESALY
LLY
RHHBY
Tags
General
RHHBY
News
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.